IQST iQSTEL Inc (QX)

 

Filed Pursuant to Rule 424(b)(7)

Registration No. 333-277029

 

PROSPECTUS SUPPLEMENT NO. 1

(To prospectus dated April 11, 2024)

 

 

iQSTEL Inc.

 

48,888,890 Shares of Common Stock

 

This prospectus supplement updates and amends the selling shareholders (each, a “selling shareholder” and collectively, the “selling shareholders”) information contained in the prospectus dated April 11, 2024 (the “Prospectus”), which forms a part of the Registration Statement on Form S-1 (File No. 333-277029) of iQSTEL Inc. (the “Company”, “we”, “our” or “us”), and relates to the resale of an aggregate of 48,888,890 shares of our common stock, including 3,535,354 shares of common stock, 35,353,536 shares of common stock issuable upon conversion of a secured convertible promissory note (the “Note”) and 10,000,000 shares of common stock issuable upon exercise of a common stock purchase option (the “Option”).

 

This prospectus supplement is being filed solely for the purpose of updating the information of the selling shareholders described below.

 

This prospectus supplement is not complete without, and may not be utilized except in connection with, the Prospectus, including any amendments or supplements thereto.

 

Investing in our securities involves a high degree of risk. Before investing in our securities, you should carefully consider the risks and uncertainties described under the caption “Risk Factors” of the Prospectus and under similar headings in the documents incorporated by reference herein and therein.

 

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus supplement. Any representation to the contrary is a criminal offense.

 

The date of this prospectus supplement is June 5, 2024. 

 

 

SELLING SHAREHOLDERS

 

The shares of common stock being offered by the selling shareholders are those currently held by the selling shareholders and those issuable to the selling shareholders pursuant to the terms of the Note and Option.

 

For purposes of this prospectus, “selling shareholders” mean the shareholders listed below and their permitted transferees, pledgees, assignees, distributees, donees or successors or others who later hold any of the selling shareholders’ interests in the securities. To the extent required, we will file a supplement to this prospectus (or a post-effective amendment hereto, if necessary) to name successors to the named selling shareholder who are able to use this prospectus to resell the common shares registered hereby.

 

Except for the ownership of the Note and Option, the selling shareholders have not had any material relationship with us within the past three years.

 

The table below lists the selling shareholders and other information regarding the beneficial ownership of the shares of common stock by each of the selling shareholders. The second column lists the number of shares of common stock beneficially owned by the selling shareholders, based on their ownership of the shares of common stock, the Note and Option, as of the date of this prospectus, assuming full conversion of the Note and full exercise of the Option held by the selling shareholders on that date, without regard to any limitation on conversion.

 

In accordance with the terms of the Registration Rights Agreement with the holder of the Note and the agreement to register the shares underlying the Option, this prospectus generally covers the resale of that number of shares of common stock equal to the number of shares of common stock currently held by the selling shareholders and the number of shares of common stock issuable upon conversion and exercise of the Note and Option, respectively, until all of the shares may be sold without any restrictions pursuant to Rule 144 of the Securities Act.

. 

The amounts listed in the third and fourth columns reflect the number of shares being offered by the selling shareholders and the number of shares remaining following the sale of such shares, respectively.

 

Under the terms of the Note and Option, the selling shareholders may not convert or be issued shares of common stock to the extent such conversion or issuance would cause such selling shareholder, together with its affiliates and attribution parties and any group of which it is a member, to beneficially own a number of shares of common stock which would exceed 4.99% of our then outstanding common stock following such conversion or issuance. The number of shares in the second and fourth columns do not reflect this limitation. The selling shareholders may sell all, some or none of their shares in this offering. See “Plan of Distribution.”

 

Name and Address of Selling Shareholder		Number of Shares of Common Stock Owned Prior to Offering (1)				Maximum Number of Shares of Common Stock to be Sold Pursuant to this Prospectus				Shares of Common Stock to be Owned After Offering (1)
M2B Funding Corp. (2)			3,535,354				38,888,890				0%
ADI Funding LLC (3)			0				10,000,000				0%

  

	(1)	“Beneficial ownership” is a term broadly defined in Rule 13d-3 under the Exchange Act and includes more than the typical form of stock ownership, that is, stock held in a person’s name. The term also includes what is referred to as “indirect ownership,” meaning ownership of shares as to which a person has or shares investment power. For purposes of this column, a person or group of persons is deemed to have “beneficial ownership” of any shares that are currently exercisable or exercisable within 60 days of the date of this prospectus.   The amounts listed do not give effect to any limitation on conversion or the issuance of shares pursuant to the terms of the Note or Option (including the limitations on beneficial ownership discussed above).
	(2)	Daniel Kordash holds voting and dispositive power over the shares of common stock beneficially owned by M2B Funding Corp. Includes (i) 3,535,354 shares of common stock and (ii) 35,353,536 shares issuable upon conversion of the Note held by the selling stockholder (but without giving effect to the limitation on beneficial ownership contained therein).
	(3)	Ariella Basdeo holds voting and dispositive power over the shares of common stock beneficially owned by ADI Funding LLC. Includes 10,000,000 shares issuable upon exercise of the Option held by the selling stockholder (but without giving effect to the limitation on beneficial ownership contained therein).

 

 

---